Shifting the standard of care in medicine is a complex process that relies on more than just technological advancement or regulatory approval. According to Erez Meltzer, CEO of Nanox, three key forces drive the adoption of new medical innovations. These include the presence of internal champions who advocate for the technology, the generation of evidence that inverts the risk calculus for adoption, and the alignment of guidelines, reimbursement, and regulatory pathways. Meltzer uses the example of 3D mammography (DBT) to illustrate how, despite FDA approval in 2011 and clear evidence of improved detection rates, it took nearly a decade for DBT to become widely adopted due to these factors. AI
RANK_REASON The item is an opinion piece by a CEO discussing general principles of medical innovation adoption, not a specific event.
- 3-D mammography
- digital breast tomosynthesis
- Erez Meltzer
- The Journal of the American Medical Association
- United States Food and Drug Administration
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
